• 

  France, UK Insurers Say They Won’t Cover Alzheimer’s Drug Leqembi
• 

  OP-ED: How Hospice Care Falls Short for People Living With Dementia
• 

  New State Laws Require Insurance to Cover Alzheimer’s Biomarker Tests
• 

  STUDY: Many Pay Out of Pocket for Home Care, Despite Medicaid
• 

  States Propose Bills to Make Private Insurers Cover Approved Alzheimer’s Drugs, Diagnostics
• 

  UK Insurance Didn’t Want to Cover Leqembi. Now, It Says It Won’t Cover Kisunla, Either
• 

  What Happens When Insurance Refuses to Cover Your Alzheimer’s Prescription?
• 

  Dental Care Is Crucial to Brain Health—Why Doesn’t Medicare Cover It?
• 

  Insurers Could Deny Coverage to People With Alzheimer’s Risk Genes
• 

  What You Need to Know About Long-Term Care Insurance in the U.S.
• 

  4 Frustrating Things I Learned Reporting On Alzheimer’s Blood Tests
• 

  Alzheimer’s Biomarker Tests Could Screw Up Your Insurance
• 

  Does Medicare Cover Amyloid PET Scans for Alzheimer’s?
• 

  With Full FDA Approval, Alzheimer’s Drug Leqembi Now Covered By Medicare
• 

  Phil’s Journal: What Is ‘Quality of Life?’ A Sad Farewell and a Tough Deciscion

12Next